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ARE POLYPHOSPHORYLATED PHOSPHOLIPIDS INVOLVED 
IN THE HORMONAL CONTROL OF CHOLESTEROL 
SIDE-CHAIN CLEAVAGE ACTIVITY IN TUMOUR 
LEYDIG CELLS? 
P. TERPSTRA*, F. F. G. ROMMERTS and H. J. VAN DER MOLEN~ 
Department of Biochemistry (Division of Chemical Endocrinology), Medical Faculty, Erasmus 
University, Rotterdam, The Netherlands 
(Received 16 August 1984) 
Summary-The possible role of LH or dcAMP induced changes in polyphosphorylated phospholipid 
metabolism in the regulation of cholesterol side-chain cleavage activity has been studied in tumour Leydig 
cells. Mitochondria isolated from LH-stimulated Leydig cells were 400% more active in pregnenolone 
production than mitochondria from control cells. Steroid production in isolated mitochondria from 
control cells could be stimuldted only 25% by cytosol fractions from stimulated cells and 1OOpM 
phosphatidyl inositol-4’-phosphate (PtdIns4P). Other polyphosphorylated phospholipids were either 
inactive or showed aspecific effects. During a preincubation period tumour cells were labelled with 
[‘*P]phosphate and steady-state labelling was obtained for the pholyphosphorylated phospholipids after 
40-60 min. [‘*PIPhosphate incorporation in Ptd InsclP, phosphatidyl inositol (PtdIns), phosphatidyl 
choline (PtChl), phosphatidyl ethanolamine (PtdEtn) and cardiolipin (CL) was not at&ted by treatment 
of the Leydig cells with LH which stimulated (bfold), or with cycloheximide which suppressed (4-fold) 
steroid production. A 25% increase of phosphate incorporation by LH was observed only in phosphatidyl 
inositoW,S-biphosphate (PtdIns4,5P,). 32P Incorporation in PtdIns4,5P,, PtdIns,PtdEtn and CL was 
stimulated by quinacrine 50 PM. Under these conditions the LH-stimulated pregnenolone production but 
not the 25-hydroxycholesterol dependent pregnenolone production, was completely inhibited. The results 
obtained with isolated mitochondria and intact cells indicate that increased levels of polyphosphorylated 
phospholipids are not consistently correlated with increased mitochondrial pregnenolone production. This 
argues against an important role of polyphosphorylated pohospholipids in the hormonal regulation of 
cholesterol side-chain cleavage activity in tumour Leydig cells. 
INTRODUCTION 
Stimulation of steroid production in Leydig cells by 
lutropin (LH) is correlated with a sharp rise in the 
CAMP level [l-4] and phosphorylation of specific 
proteins by CAMP-dependent kinases [5-71. However 
it is not yet which phosphorylated proteins are in- 
volved in regulation of steroid production and how 
the activation signal is propagated in the cell. 
The rate-limiting step in the control of steroido- 
genesis is the cholesterol side-chain activity which 
requires cytochrome P450 (P450,), located in the 
inner mitochondrial membrane. Trophic hormones 
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Netherlands. 
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Abbreviations: LH: lutropin. ACTH: adrenocorticotropic 
hormone. dbcAMP: N6-2’-0-dibutvrvl adenosine 
cyclic-3’, S-monophosphate. PtdIns: _ phosphatidyl 
inositol. PtdIns4P: phosphatidyl inositol-4’-phosphate. 
PtdIns4,5P,: phosphatidyl inositol-4’,5’-biphosphate. 
PtdChl: phosphatidyl choline. PtdEtn: phosphatidyl 
ethanolamine. PA: phosphatidic acid. CL: cardiolipin. 
P450,: cholesterol side-chain cleavage cytochrome 
P450,. 
increase the binding of cholesterol to P450,, which 
is followed by an increased synthesis of 
pregnenolone [8]. As in the adrenal cortex [9, lo] in- 
hibitors of protein synthesis, like cycloheximide and 
puromycin rapidly terminate the stimulated steroid 
production in the testis [l 1, 121. This indicates that a 
rapidly turning-over protein in may be involved in the 
regulation of cytochrome P450,. Recently, an 
ACTH-dependent peptide that can stimulate cyto- 
chrome P450, in isolated mitochondria has been 
isolated from adrenal tissue [13]. Changes in pho- 
pholipid metabolism may also play an important role 
in the transduction of signals through cellular mem- 
branes. It has been shown in the last years that rapid 
changes in phosphoinositol metabolism in the plasma 
membrane can occur after binding of particular 
hormones to receptors. The key event seems to be the 
receptor mediated hydrolysis of PtdIns4,5P,, which 
may take place within a minute after binding of the 
hormone. This is followed by an increase in the 
intracellular free calcium concentration by inositol 
triphosphate and activation of protein kinase C by 
diacylglycerol[14]. 
Farese et al. [15-171 have suggested, that phos- 
phoinositides may also play a role at the level of the 
mitochondria in the regulation of the cholesterol 
side-chain cleavage activity. They have observed that 
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the amount of polyphosphorylated phospholipids, 
such as PtdIns4,5P, and PrdIns4P, increased conco- 
mitantly with the hormonal stimulation of steroid 
production in adrenal cells and Leydig cells [15-181. 
These sustained effects of hormones on increased 
levels of cellular polyphosphorylated phospholipids 
are different from the rapid and transient effects of 
particular hormones on hydrolysis of poly- 
phosphorylated phospholipids in the plasma mem- 
branes. It was also found that isolated mitochondria 
from adrenals could be stimulated directly by these 
phospholipids [19]. Moreover purified cytochrome 
P450,, in liposomes could be activated by phos- 
pholipids, especially cardiolipin [20]. These obser- 
vations indicate that polyphosphorylated phos- 
pholipids may be involved in regulation of 
mitochondrial pregnenolone production in steroido- 
genie tissues in general. However, data obtained from 
experiments with ovarian tissue [12, 221, did not sup- 
port this model. It seemed of interest therefore to 
investigate the role of polyphosphorylated phos- 
pholipids in the hormonal regulation of cholesterol 
side-chain cleavage in tumour Leydig cells, which can 
be obtained pure and in large quantities and which 
have been used previously for investigating the mech- 
anism of action of LH on steroid production [7, 121. 
EXPERIMENTAL 
Materials 
Sheep lutropin (NIH-LH-S18; 1.03 i.u./mg) 
was a gift from the NIAMDD, Bethesda, MD, 
U.S.A. ACTH,_,, was a gift from Organon, Oss, The 
Netherlands [32P]Orthophosphate (carrier-free) was 
purchased from Amersham, U.K. Cyanoketone 
(2cc-cyano- 17/I-hydroxy-4,4’,17-trimethylandrost-5- 
en-3-one), an inhibitor of 3fi-hydroxysteroid 
dehydrogenase activity and SU-10603 (7-chloro- 
3,4-dihydro-2-(3-pyridyl)-naphtalen-l(ZH)-one), an 
inhibitor of 17P-hydroxylase activity, were kindly 
donated by Dr R. Neher from the Friedrich Miescher 
Institute, Basle, Switzerland. Crude collagenase was 
obtained from Worthington, U.S.A. quinacrine (me- 
pacrine, N4-(6-chloro-2-methoxy-9-acridinyl)-N’,N’- 
diethyl-1,4_pentanediamine) and phospholipids were 
obtained from Sigma, U.S.A. DibutyrylxAMP was 
obtained from Boehringer, F.R.G. 
Isolated Leydig cells 
Isolation of the tumour cells and the properties of 
these cells have been described previously [12]. Cells 
were preincubated and incubated under an O,/CO, 
(19: 1) atmosphere in a shaking waterbath (80 cpm) at 
32°C in Krebs-Ringer buffer without phosphate 
(118mM NaCl; 4.75 mM KC1/25 mM 
NaHC0,/1.2 mM MgSOJ2.5 mM CaCl,), pH 7.3, 
containing 0.2% glucose. Unless indicated otherwise, 
the preincubation time was 1 h. In some experiments 
1 mM p-aminogluthetimide was added during this 
preincubation and washed out thereafter. Incu- 
bations were carried out in 200~1 Krebs-Ringer 
buffer, containing l-2 x lOh cells, The time of addi- 
tion of lutropin (1000 ng/ml final concentration) or 
dbcAMP (130pM, final concentration) was taken as 
time zero. When pregnenolone production was mea- 
sured, cyanoketone and SU-10603 were added also at 
time zero at a final concentration of 5 p M and 19 p M 
respectively. After 1 h the incubation was terminated 
through addition of ethyl acetate (3 ml) and preg- 
nenolone was measured by radioimmunoassay [23]. 
Subcellular fractions 
To study the effect of Leydig tumour supernatant 
fractions on pregnenolone production by mito- 
chondria, the following procedure was used. Tumour 
Leydig cells were divided into two equal portions. At 
time zero lutropin was added to one portion, medium 
to the other. After 30 min the cells were spun down 
(10 min at 1OOg) and resuspended in 250 mM 
sucrose/l0 mM Tris-HCl/O.OS mM EDTA, pH 7.4 
(STE buffer), at a concentration of 30 x lo3 cells/ml. 
The cell suspension (15 ml) was homogenized at 0°C 
with a Dounce glass homogenizer (clearance 
0.03 mm). 
After 8-10 strokes 65% of the ceils were broken. 
Intact cells were removed by centrifugation for 5 min 
at 1OOg. The nuclei were sedimented after centrifu- 
gation for 10min at 1OOOg. The mitochondria and 
the postmitochondrial supernatant (PMS) were iso- 
lated after 10 min at 15000 g (for characterization see 
Bakker et al., 6). The mitochondrial pellet was care- 
fully resuspended (with a glass-Teflon homogenizer) 
in 12 ml of incubation medium, containing 100 mM 
sucrose-50mM Tris-HCI 60 mM KC1 5 mM 
MgCI,/5 mM isocitrate pH 7.4 [24]. One tenth vol- 
ume of a solution containing 55 mM MgCI, and 
55 mM isocitrate was added to the PMS fraction or 
a portion of STE buffer. Mitochondrial suspensions 
(0.25 ml) from stimulated or unstimulated cells were 
combined with an equal volume of PMS from stimu- 
lated or unstimulated cells or with STE buffer supple- 
mented as described above. When production of 
pregnenolone was measured in subcellular fractions 
cyanoketone and SU-10603 were added as described 
above. The incubation was terminated after 15 min 
with the addition of ethylacetate. Addition of 
NADPH to the incubation mixture had no effect on 
pregnenolone production. This indicates that the 
inner mitochondrial membranes were intact. The 
pregnenolone production of PMS alone was less than 
1% of the mitochondrial pregnenolone production. 
To study the effect of added phospholipids, mito- 
chondria were isolated directly from unstimulated 
tumour tissue by homogenization in STE buffer, 
using a glass-Teflon potter tube (800 rpm, 5 strokes, 
0°C) followed by differential centrifugation. The 
mitochondrial pellet was resuspended in incubation 
medium. Incubation (15 min at 32°C) was started 
with the addition of a concentrated solution, contain- 
ing phospholipid, cyanoketone and SU-10603. The 
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Fig. 1. Effect of supematant fractions from tumour Leydig 
cells on pregnenolone production by isolated mitochondria. 
The three bars at the left represent mitochondria from 
control cells; the three bars at the right mitochondria from 
lutropin-stimulated cells. Open bars: addition of super- 
natant medium only; stippled bars: addition of supematant 
from control cells; hatched bars: addition of supematant 
from lutropin-stimulated cells. Values are means f SD of 4 
different mitochondrial preparations. *Significantly 
different (P < 0.01) when compared to mitochondria with 
supematant from control cells. One-hundred represents 
140 ng pregnenolone/mg mitochondrial protein/l 5 min; 
protein concentration during incubation: mitochondrial 
protein 250 pg/ml; supematant protein 600 pg/ml. 
phospholipids were dissolved in chloroform- 
methanol-H,0 or ethanol. Before addition they were 
concentrated in 35 pl propyleneglycol by evaporation 
of the solvents with NZ. Then 315 pl incubation 
medium was added and after extensive vortexing the 
appropriate amount was added to the incubation 
media. 
Phospholipiak 
Cellular phospholipids were labelled as follows: 
after a 30 min preincubation of the cells SOpCi 
[“Plorthophosphate was added to the cells and the 
preincubation was continued for 60 min. At time zero 
stimulators or inhibitors were added. After 60min 
the incubations were terminated by addition of ice- 
cold extraction mixture. Parallel incubations without 
[32P]phosphate but with cyanoketone and W-10603 
added at time zero were used to measure the preg- 
nenolone production of the cells. 
Phospholipids were extracted using the acid 
chloroform/methanol procedure described by Jolles 
et al. [25]. In our hands this method worked better 
than a neutral extraction procedure [15,26], because 
twice the amount of phospholipids was extracted 
from the same batch of labelled cells. Re-extraction 
of a freshly labelled phospholipid extract added back 
to unlabelled cells gave a recovery of 85% for the acid 
extraction procedure without specific losses for indi- 
vidual phospholipids, as compared to 70% for the 
neutral extraction procedure with specific losses for 
polyphosphorylated phospholipids. 
Analysis of phospholipids was carried out 
immediately after extraction on Merck HPTLC 
plates (Kieselgel 60, without fluorescence indicator) 
impregnated with potassium oxalate and developed 
in chloroform-acetone-methanol-acetic acid-H, 0 
(40: 15: 13: 12:8, by vol) for 45 min [27,28]. 
Phospholipids were visualized using I, vapour and 
autoradiography. Individual spots were scraped off 
the plate and their radioactivity was determined in 
Picofluor 15 scintillation fluid (Packard). R, values 
for individual phospholipids in this system are: 
phosphatidyl-inositol-4’-5’-bisphosphate: 0.21; phos- 
phatidyl-inositol-4’-phosphate: 0.27; phosphatidyl- 
inositol: 0.37; phosphatidyl-choline: 0.41-0.48; 
phosphatidyl-serine: 0.61; phosphatidyl-ethano- 
lamine: 0.70; phosphatidic acid and cardiolipin: 0.78. 
After chromatography no radioactivity was detected 
at the application point. Recovery of radioactivity 
from the TLC plates was greater than 90%. The 
“P-label incorporated in the individual phospholipids 
by lo6 cells incubated under different conditions was 
expressed relative to the activities obtained from cells 
incubated with cycloheximide; the latter was taken as 
100%. The different incubation conditions of the cells 
did not influence the amount of “P-label incorpo- 
rated in the total phospholipid fraction extracted 
from the cells. Incorporation of ‘*P in this total 
phospholipid fraction varied not more than 10% 
between duplicate incubations. Protein was deter- 
mined by the Lowry method, with BSA as standard. 
Statistical significance of results was calculated using 
the Student’s t-test. 
RESULTS 
The pregnenolone production in the cells from 
which the mitochondria were isolated was stimulated 
6-fold by LH when compared with controls. Mito- 
chondria isolated from LH-stimulated tumour Ley- 
dig cells in the presence of isocitrate retain their 
increased capacity to produce pregnenolone (Fig. 1). 
There was a Cfold difference in specific activity of 
steroid production between mitochondria of stimu- 
lated and unstimulated cells. 
Addition of supematant fractions from LH-treated 
cells to mitochondria from untreated cells gave a 
small (25%) but significant rise in pregnenolone prod- 
uction (Fig. 1). 
The effect of added phospholipids on the preg- 
nenolone production of isolated mitochondria from 
unstimulated tumour cells is shown in Fig. 2. Phos- 
phatidyl choline had no significant effect. Cardiolipin 
stimulated pregnenolone production approx 20% at 
0.1 mM, but this effect disappeared at 0.4 mM. 
PtdIns4,5P2 had no effect, but PtdIns4P caused a 50% 
stimulation. Pregnenolone production could not be 
increased by addition of cholesterol (50 PM) in the 
incubation medium or by pretreatment of the cells 
with p-aminogluthetimide (data not shown). 
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Fig. 2. Effect of phospholipids on pregnenolone production 
by mitochondria isolated from tumour Leydig cells. 
Mitochondria from tumour tissue were incubated with 
various phospholipids at the indicated concentrations. 
100% = 150 ng pregneno~one/mg mit~hondrial protein/ 
1.5 min; protein concentration during incubation: 500 pg/ml. 
Values are means + SD of 4 different mitochondrial incu- 
bations. **P < 0.01 vs control; *P < 0.05 vs control. 
Addition of phospholipids to intact isolated tu- 
mour Leydig cells caused a significant stimulation of 
pregnenolone production, but this stimulation was 
non-specific with respect to the nature of the phos- 
pholipid added and was much smaller than the 
stimulation that could be reached by addition of 
dibutyryl CAMP (Fig. 3). 
In the next series of experiments we have studied 
the effect of compounds that inhibit or stimulate 
steroid production on phospholipid metabofism and 
steroid production in intact cells. Quinacrine is an 
inhibitor of phospholipase A, 129,391 and was added 
because inhibition of the metabolism of phos- 
pholipids might increase the steady state concen- 
trations of poI~hosphorylated phospholipids. Quin- 
acrine, however, inhibited steroid production in 
control and dbcAMP-stimulated cells progressively 
(Fig. 4). Similar results were obtained when 1 pg 
LH/ml was used instead of dcAMP (data not shown). 
At a quinacrine concentration of 6pM LH- or 
dcAMP-dependent steroid production was inhibited 
by 50%. However, in the presence of 32pM 
25-OH-cholesterol none of the quinacrine concen- 
trations used inhibited pregnenolone production 
more than IS%, indicating that quinacrine does not 
inhibit cytochrome P450, activity itself. Effects of 
LH, cycloheximide and quinacrine on the metabolism 
of phospholipids in cells were investigated after cells 
had been labelled with [32P]phosphate until a steady 
state incorporation of [“P] into PtdIndP, 
PtdIns4,5P,, PA and CL was reached (Fig. 5). Due to 
the short labelling period the PtdEtn, PtdChl and to 
a lesser extent PtdIns were not labelled to constant 
specific activity. Cycloheximide inhibited the steroid 
production in tumour Leydig cells incubated without 
LH [31]. We have therefore taken the cycloheximide 










Fig. 3. Effect of dbcAMP and phospholipids on preg- 
nenolone production by tumour Leydig cells. Phospholipids 
were added to the cells to a final concentration of 200 PM; 
dbcAMP to a concentration of 130pM. The incubation 
time was 1 h; thereafter pregnenolone was determined. IO6 
Leydig cells contain approx 17Opg protein. Values are 
means f SD from 3 cells preparations. **P < 0.005 vs con- 
trol; l P < 0.05 vs control. 
right panel). The change in (32P)-labelling of indivi- 
dual phospholipids under various conditions was 
expressed in the same way: cycloheximide treated 
cells were taken as 100’~ (Fig. 6: left panel). No 
significant differences in phospholipid labelling could 
be detected when the untreated and cycloheximide- 
treated cells were compared. Cells stimulated with 
LH showed a go-fold increase in pregnenlone prod- 
uction with respect o cycloheximide-treated metabo- 
pM quinacrioe 
Fig. 4. Effect of quinacrine on control and dcAMP- 
stimulated pregnenolone production by tumour Leydig 
cells. At time zero quinacrine alone (A-A) or quin- 
acrine with dbcAMP (130 #M) (*---0) was added and 
the incubation was carried out for 1 h. Values are 
means f SD from three different cell preparations. 
Phospholipids and tumour Leydig cells 177 
30 60 90 min 30 60 90 ah 
Fig. 5. Kinetics of 3zP phosphate incorporation into individual phospholipids from tumour Leydig cells. 
Tumour Leydig cells were incubated with ‘T’ phosphate for various time periods. Phopholipids were 
extracted and analyzed as described in the Experimental Section. No hormones or inhibitors were added. 
Open circles: phosphatidic acid and cardiolipin; closed circles: phosphatidyl-inositol 4 phosphate; open 
triangles: phosphatidyl-inositol; closed triangles: phosphatidyl-inositol 4,5 bis phosphate; open squares: 
phosphatidyl-ethanolamine; closed squares: phosphatidyl-choline. 
lism were not significant, except for a small increase determine the effects of LH on the mass of individual 
(25%) for PtdIns4,5P,. Similar data were obtained phospholipids directly, but due to the fact that the 
when effects of LH were measured 10 or 60 min after polyphosphorylated phospholipids were labelled to 
addition of the hormone, or when dibutyryl CAMP constant specific activity it seems reasonable to con- 
was used instead of LH. Due to the low concentration chide that changes in incorporation of label reflect 
of polyphosphorylated phospholipids in extracts of changes in the mass of these phospholipids. This does 
2 x lo7 tumour Leydig cells, it was not possible to not hold for PtdIns, PrdEtn and PtdChl. The discrep- 
R ‘; I 
PtdChl PtdEtn PA +CL 
Fig. 6. Effect of cycloheximide, lutropin and quinacrine on steroidogenesis and [32P] incorporation in 
phospholipids in tumour Leydig cells. Sixty min after addition of [“?]phosphate the following additions 
were made to the cells: open bars: cycloheximide (80 PM); stippled bars: medium; diagonally hatched bars: 
lutropin (1 pg/ml); uertically hatched bars: quinacrine (50 FM) + LH(1 pg/ml) and the incubations were 
continued for 1 h. The phospholipids were extracted and analyzed using thin-layer chromatography. The 
amount of label in the individual phospholipid spots from the cycloheximide incubation was set as 100% 
(see Results sections). Values are means +_ SD from 4 different cell preparations. The distribution of 
32P-label in the individual phospholipids was on the average (expressed as o/o from the total “P-label 
extracted): PtdIns4,5P,: 4%; PtdIns4P: 3% PtdIns: 15%; PtdChl: 67%; PtdEtn; 8%; PA and CL: 3%. *(Left 
panel): significantly different (P < 0.05) when compared to cycloheximide incubation. The 100% in the 
right panel represents: 1.5 ng pregnenolone/106 cells/h. *Right panel): significantly different from the 
cycloheximide incubation: P c 0.001 (lutropin) and P c 0.01 (control and quinacrine). 
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ancies between phosphohpid metabolism and steroid 
production were most marked when the effect of 
quinacrine was investigated in the presence of LH. A 
significant increase in the labelling of PtdIns4,5P,, 
ptdIns, PtdEtn and PA plus Cl was observed, 
whereas LH stimulated pregnenolone production was 
strongly inhibited by quinacrine (Fig. 6). 
DISCUSSION 
It has been shown that protein synthesis is required 
for LH action on pregnenolone production [7, 111 
and that the 22000, 24000 and 33000 Da phos- 
phoproteins in the microsomal fraction may be in- 
volved in the regulation of protein synthesis and 
steroidogenesis by LH [7]. Farese et al. have proposed 
that polyphosphorylated phospholipids may also be 
involved in the control of cytochrome P450, in 
Leydig cells and adrenals [14-181. It has been sug- 
gested that LH-dependent rapidly turning over pro- 
teins control the changes in polyphosphorylated 
phospholipid metabolism [32]. 
We have investigated whether phospholipids can 
regulate the mitochondrial cholesterol side-chain 
cleavage in tumour Leydig cells. The present results 
show that mitochondria isolated from LH-stimulated 
cells were 4-fold more active than mitochondria from 
control cells. Thus, Leydig cell mitochondria can 
retain their stimulated activity after the isolation 
procedure, which makes it possible to compare pro- 
perties of isolated mitochondria with those of mito- 
chondria in situ. Only a small stimulation (25%) by 
cytosols from activated cells on mitochondria form 
control cells could be detected. These data confirm 
results from previous studies with whole testis 
mitochondria [33]. That only a small stimulation is 
measured may be explained by turnover of active 
compounds or by the presence of inhibitors of choles- 
terol side-chain cleavage in the cytosols [34, 351. The 
cytochrome P450, in isolated Leydig cell mito- 
chondria was stimulated with PtdIns4P and to some 
degree also with CL, but other phospholipids were 
not active. The stimulating effects could be obtained 
only at unphysiologically high concentrations 
(100 PM) of phospholipids. In addition, phos- 
pholipids at these high concentrations may have a 
nonspecific effect, as reflected in the small stimulatory 
effects of all phospholipids on intact Leydig cells. 
Such results do not support the general conclusion of 
Farese [32], that the specific polyphosphorylated state 
of the phospholipid is the essential factor in the 
regulation of cholesterol side-chain cleavage in iso- 
lated mitochondria. A similar discrepancy between 
adrenal and gonadal steroid production was observed 
by Tanaka et al. [21], who could stimulate corpus 
luteum mitochondria only with 100pM concen- 
trations of cardiolipin but not with PtdIns4P. The 
high concentrations of phospholipids required for 
stimulation of isolated mitochondria and the 
conflicting results on the specificity render the im- 
portance of polyphosphorylated phospholipids for 
the regulation of cholesterol side-chain cleavage 
activity in intact cells questionable. 
If phospholipids are mediators of the action of 
trophic hormones on mitochondrial steroid prod- 
uction, a correlation between hormonal effects on 
phosphohpid metabolism and steroid production 
would be expected. Changes in phospholipid metabo- 
lism and steroid production were therefore in- 
vestigated in intact cells incubated in the presence of 
compounds which stimulate or inhibit steroido- 
genesis. A small stimulation of only PtdIns4,5P, 
synthesis could be measured after addition of LH. 
However, this stimulation could only be shown when 
compared with cycloheximide inhibited cells and not 
when compared with untreated cells. The production 
of other phospholipids was not affected by addition 
of LH, whereas the activity of steroid production 
could be increased more than go-fold. Therefore, the 
functional importance of this stimulatory effect of 
LH on PtdIns4,5P, synthesis in the regulation control 
of cholesterol side-chain cleavage activity is not clear. 
These results are different from those published by 
Lowitt et al. [ 181 who extracted phospholipids from a 
few million testicular Leydig cells and reported a 
significant increase in cellular levels of phospholipids 
after stimulation of the cells with LH or 1 mM 
dcAMP, but not with 0.1 mM dcAMP. We have not 
been able to measure significant effects of LH on the 
mass of polyphosphorylated phospholipids after 
extraction of twenty million tumour Leydig cells 
(unpublished results). 
Cholesterol side-chain cleavage activity in the pres- 
ence of 2Shydroxycholestero1, which reflects the 
maximal mitochondrial steroid production [33, 361 
was not inhibited by quinacrine. This suggests that 
quinacrine does not inhibit mitochondrial activities 
which are important for steroidogenesis. Addition of 
quinacrine resulted in increased labelling of 
PtdIns4,5P,, PA and CL in tumour Leydig cells and 
therefore probably increased the levels of these phos- 
pholipids. This may be expected since quinacrine is 
an inhibitor of phospholipase A, [29, 301 and thus 
prevents breakdown of precursors of poly- 
phosphorylated phospholipids. The increase in the 
levels of polyphosphorylated phospholipids should 
case a stimulation of cholesterol side-chain cleavage 
activity if these phospholipids were the final media- 
tors of the hormone-dependent activation of the 
mitochondrial steroid production. However, preg- 
nenolone production in the presence of quinacrine 
was not stimulated but inhibited. 
These results obtained with tumour Leydig cells 
show that there is no clear-cut correlation between the 
level of polyphosphorylated phospholipids and the 
activity of cytochrome P450, under different experi- 
mental conditions. We conclude therefore that poly- 
phosphorylated phospholipids apparently do not 
play an important role in the regulation of cholesterol 
side-chain cleavage activity after stimulation of 
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tumour Leydig cells with LH. The exact role of 
polyphosphorylated phospholipids in the regulation 
of steroidogenesis in corpus luteum cells is also 
disputed [21,22], although effects of LH on phos- 
phate incorporation in phospholipids have been 
observed[22]. A number of papers have been 
published on the role of phosphoinositides in the 
hormonal control of adrenal steroidogene- 
sis [15-19,24,32], and the authors suggest hat poly- 
phosphorylated phospholipids play an important role 
in the regulation of cytP450, in the adrenal gland. 
The discrepancies between the results obtained by 
Tanaka and Strauss [21], Davis et al. [22] and in the 
present paper on one hand and those obtained by 
Farese et al. [l S-19,24,32] on the other hand cannot 
be explained at the moment. More experiments 
should be carried out in order to test the hypothesis 
whether trophic hormones increase cytP450, activity 
via sustained increased levels of polyphosphorylated 
phospholipids, especially since stimulating effects of 
certain hormones can be expressed via rapid hydro- 
lysis of polyphosphorylated phospholipids in cell 
membranes [ 141. 
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